Aspen will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.
Products are manufactured at Aspen sites or sourced from reputable third-party suppliers. Manufacturing sites are required to comply with GMP, which governs the manufacture of products in the pharmaceutical industry and to uphold the status of pharmaceutical regulatory approvals applicable to the supplied territories.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam id nisl in urna euismod pellentesque vitae vitae mauris. Suspendisse faucibus ex sed convallis dignissim.
Name, Group Marketing Head
We believe that doing business in a sustainable and responsible manner is integral to our purpose, our values and our philosophy “Healthcare. We Care”.
Our sustainability commitments are integrated into the Group’s strategic objectives and underpin the way we do business.
Our sustainability commitments are integrated into the Group’s strategic objectives and underpin the way we do business.
We constantly search for better ways of doing things
We strive to be the best we can be to deliver the highest standards
We go the extra mile, seeking to exceed expectations
We optimise our performance by pulling together
Our integrity is not negotiable
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600
Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa